Crossmark

Concurrent estimation of lamivudine, tenofovir disoproxil fumarate, and efavirenz in blended mixture and triple combination tablet formulation by a new stability indicating RP-HPLC method

Crossref DOI link: https://doi.org/10.1186/s43094-021-00249-9

Published Online: 2021-04-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Godela, Ramreddy http://orcid.org/0000-0003-4334-7162
Kammari, Vijayalaxmi

Gummadi, Sowjanya

Beda, Durgaprasad
License Information

Text and Data Mining valid from 2021-04-30

Version of Record valid from 2021-04-30
More Information

Article History

Received: 30 July 2020

Accepted: 16 April 2021

First Online: 30 April 2021

Declarations

:

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below